Dow Jones Top Energy Headlines at 4 PM ET: Crude Settles Lower With Market Focus on Iran | U.S. ... Crude futures posted ...
For the quarter, Ford reported total revenue of $45.9 billion, down 5% from the year-ago period but ahead of Wall Street's ...
Dow Jones Top Company Headlines at 7 PM ET: Ford Discloses Additional $900 Million Tariff Hit | FDA ... Detroit automaker reported its largest ever quarterly loss on EV-related charges. The company ...
Dow Jones Top Markets Headlines at 7 PM ET: U.S. Retail Sales Unexpectedly Flat in December | AI ...
Dow Jones Top Markets Headlines at 7 PM ET: U.S. Retail Sales Unexpectedly Flat in December | AI ... The softer-than-expected data feed into economists' concerns about a fragile consumer economy ...
OTTAWA--Canada's state-owned agricultural lender says it has received billions in pledges from private-equity firms and one ...
Estée Lauder has filed a lawsuit against Walmart alleging the retailer sold knockoff versions of some of cosmetics company's fragrances and skin-care products. The lawsuit, filed in federal court in ...
Shopify reports earnings on Wednesday morning. Shopify's stock got hit last week on broader fears about the threat of "vibe-coded" software, but now it's in the midst of a comeback. Shares of the ...
Xylem is one of the leading water technology companies in the world. Its extensive portfolio spans a wide range of equipment and solutions for the water industry, including the transport, treatment, ...
A Deutsche Bank analyst raised her price target for Micron's stock to $500 on Tuesday. This memory cycle "is different than others," according to a Deutsche Bank analyst, and that could mean more big ...
Amplifon is the global leader in hearing care retail, operating an extensive network of over 10,000 points of sale across 26 countries. Unlike its primary listed competitors, such as Sonova and Demant ...
Investors have witnessed a number of notable developments across markets this year, including an epic boom and then bust in the prices of silver (SI00) and gold (GC00), and a powerful streak of ...
Moderna shares slid after the Food and Drug Administration refused to consider approving its new flu vaccine. The stock dropped 7% to $39.00 in after-hours trading, immediately following the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results